Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA

Slow responders to tuberculosis (TB) treatment in Virginia have prolonged treatment duration and consume more programmatic resources. Diabetes is an independent risk factor for slow response and low serum anti-TB drug concentrations. Thus, a statewide initiative of early therapeutic drug monitoring...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Heysell, Scott K., Moore, Jane L., Staley, Debbie, Dodge, Denise, Houpt, Eric R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi Publishing Corporation 2013
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3855970/
https://ncbi.nlm.nih.gov/pubmed/24349775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/129723
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items